ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

OVID Ovid Therapeutics Inc

3,34
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:21:58
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Ovid Therapeutics Inc OVID NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 3,34 10:21:58
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,34
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
04.4.202414:00GLOBEOvid Therapeutics to Present at the 23rd Annual Needham..
08.3.202414:24EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08.3.202414:20EDGAR2Form 8-K - Current report
08.3.202414:00GLOBEOvid Therapeutics Reports Business Updates, Fourth Quarter..
28.2.202414:00GLOBEOvid Therapeutics to Present at the TD Cowen 44th Annual..
27.2.202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202400:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202423:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202423:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202417:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12.2.202412:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06.2.202414:00GLOBEOvid Therapeutics to Present at the Oppenheimer 34th Annual..
06.12.202323:08EDGAR2Form 8-K - Current report
01.12.202313:30GLOBEOvid Therapeutics to Present Five Abstracts Supporting its..
16.11.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
15.11.202322:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
03.11.202321:08EDGAR2Form S-3 - Registration statement under Securities Act of..
03.11.202313:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.11.202313:10EDGAR2Form 8-K - Current report
03.11.202313:00GLOBEOvid Therapeutics Reports Third Quarter 2023 Financial..
18.10.202314:04EDGAR2Form 8-K - Current report
18.10.202314:00GLOBEOvid Therapeutics and Ligand Pharmaceuticals Enter into a..
10.10.202314:00GLOBEOvid Therapeutics to Present at the Jefferies Biotech..
02.10.202318:15EDGAR2Form 8-K - Current report
26.9.202313:30GLOBEOvid Therapeutics to Host Investor Event - R&D Day on..
20.9.202313:30GLOBEOvid Therapeutics to Present at the 2023 Cantor Fitzgerald..
30.8.202314:00GLOBEOvid Therapeutics to Participate in Upcoming September..
04.8.202315:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04.8.202315:10EDGAR2Form 8-K - Current report
04.8.202314:00GLOBEOvid Therapeutics Reports Second Quarter 2023 Financial..
01.8.202314:00GLOBEOvid Therapeutics to Present at the BTIG Virtual..
31.7.202323:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28.6.202314:00GLOBEOvid Therapeutics Expands Its Scientific Leadership Team &..
26.6.202314:00GLOBEOvid Therapeutics Added to Russell 3000® Index
05.5.202313:30GLOBEOvid Therapeutics Reports First Quarter 2023 Financial..
01.5.202312:00GLOBEOvid Therapeutics Announces Collaboration with Graviton..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock